Dr. Jay Kiran Yarlagadda, MD

Dr. Yarlagadda practices at OSF Little Company of Mary Medical Center in Evergreen Park, Illinois, part of OSF HealthCare System.

Dr. Yarlagadda's NPI, 1285029348, was assigned on April 5, 2015. Dr. Yarlagadda holds California license A155094.

Dr. Yarlagadda's primary practice is OSF Little Company of Mary Medical Center, at 2800 W 95th St, Evergreen Park, IL 60805 in Cook County. The practice phone is (708) 422-6200.

Dr. Yarlagadda's primary practice is OSF Little Company of Mary Medical Center in Evergreen Park, Illinois, part of OSF HealthCare System. The medical group on file is Inpatient Consultants of Illinois. Dmand AI also links Dr. Yarlagadda to 2 more medical groups, 1 breast imaging center and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yarlagadda practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yarlagadda's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yarlagadda is licensed in California.

CMS data shows 544 Medicare services from Dr. Yarlagadda across 4 procedure codes in 2024, for 227 Medicare patients. Medicare paid $45,891 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 227 Medicare patients who saw Dr. Yarlagadda in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yarlagadda's median patient age at 69, with 58% women.

In 2024, Dr. Yarlagadda wrote 669 Medicare Part D claims for 261 patients. 90% of them were for generic drugs. CMS names the drug for 375 of them, across 20 drugs with 11 or more claims each, at $20,458 in total drug cost. In 2023, CMS named 357 claims across 20 drugs.

Dr. Yarlagadda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Yarlagadda from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $21.